WASHINGTON — David E. Midthun, MD, FACP, professor of medicine and director of the lung cancer screening program at Mayo Clinic, discussed various aspects of lung cancer screening here at the annual American College of Physicians Internal Medicine Meeting.
Smoking is a highly modifiable risk factor for lung cancer, he said.
"The patient needs to recognize that there's potential benefit for lung cancer screening, but compared to stopping smoking, that benefit is relatively small," Midthun said. "The message should be stop smoking first, and potentially pursue CT screening as far as reducing one's chance of dying, be it of cardiovascular death or lung cancer."
Participants in his program are required to undergo smoking cessation consultations, he said, which is a step above the current CMS requirement of providing cessation literature.